Published in Am J Med Genet on February 01, 1990
Reply: the dysplastic nevus "syndrome" is not a dichotomic, but a continuous phenotype. Am J Med Genet (1990) 0.75
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Germline p16 mutations in familial melanoma. Nat Genet (1994) 5.59
Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet (1997) 5.34
Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature (1989) 4.18
Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med (1987) 4.12
Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53
CDKN2A mutations in multiple primary melanomas. N Engl J Med (1998) 3.52
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet (1996) 2.96
Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr (1998) 2.82
Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst (2001) 2.73
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst (1993) 2.44
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet (1995) 2.42
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet (1998) 2.32
The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer (1988) 2.26
Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA (1993) 2.17
Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell (1992) 2.15
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 2.11
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet (1999) 2.03
Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum Genet (1998) 1.99
Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat Genet (1995) 1.97
Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst (1990) 1.86
Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet (2001) 1.83
Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet (1998) 1.82
Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet (1998) 1.75
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Mutations associated with familial melanoma impair p16INK4 function. Nat Genet (1995) 1.69
Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med (1993) 1.66
Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med (1985) 1.64
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (1999) 1.61
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst (2000) 1.51
Problems ascertaining friend controls in a case-control study of lung cancer. Am J Epidemiol (1991) 1.48
Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium. J Clin Oncol (1999) 1.47
Collection of buccal cell DNA using treated cards. Cancer Epidemiol Biomarkers Prev (2000) 1.46
A leucine----proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell (1992) 1.46
Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst (2000) 1.45
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev (1995) 1.39
Increased risk of neuroectodermal tumors and stomach cancer in relatives of patients with Ewing's sarcoma family of tumors. J Natl Cancer Inst (1994) 1.39
Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. Am J Hum Genet (1986) 1.39
Day hospital rehabilitation--effectiveness and cost in the elderly: a randomised controlled trial. Br Med J (Clin Res Ed) (1984) 1.38
Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet (1998) 1.33
A second maternally expressed Drosophila gene encodes a putative RNA helicase of the "DEAD box" family. Proc Natl Acad Sci U S A (1991) 1.32
Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31
The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer (1988) 1.25
Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci U S A (1989) 1.21
Evidence against Ha-ras-1 involvement in sporadic and familial melanoma. Nature (1987) 1.21
A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis (2000) 1.21
Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum (1994) 1.20
Darier disease--novel mutations in ATP2A2 and genotype-phenotype correlation. Exp Dermatol (2001) 1.20
Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum (1998) 1.20
Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development. Clin Genet (2009) 1.18
The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol (2001) 1.16
Genetic epidemiology of cutaneous melanoma: a global perspective. Arch Dermatol (2001) 1.15
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients. Cancer Res (1996) 1.12
Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet (2004) 1.10
Availability of schizophrenic patients and their families for genetic linkage studies: findings from the Maryland epidemiology sample. Genet Epidemiol (1989) 1.10
A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol (1994) 1.09
Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet (1993) 1.08
Novel transglutaminase-1 mutations and genotype-phenotype investigations of 104 patients with autosomal recessive congenital ichthyosis in the USA. J Med Genet (2008) 1.06
Late effects of therapy in survivors of Ewing's sarcoma family tumors. J Pediatr Hematol Oncol (1997) 1.06
Combined risk factors for melanoma in a Mediterranean population. Br J Cancer (2001) 1.06
Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol (1994) 1.06
Clinical findings in two African-American families with the nevoid basal cell carcinoma syndrome (NBCC). Am J Med Genet (1994) 1.05
Childhood cancer in sibs. J Pediatr (1976) 1.05
Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monogr (1995) 1.04
A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4. J Med Genet (2005) 1.04
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04
Localization of the gene for the nevoid basal cell carcinoma syndrome. Am J Hum Genet (1994) 1.03
Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br J Cancer (1999) 1.01
Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer (2000) 1.01
Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control (1997) 1.00
Genetics of melanoma. Cancer Surv (1990) 1.00
Survival patterns for malignant mesothelioma: the SEER experience. Int J Cancer (1988) 1.00
Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. Biochem Biophys Res Commun (1993) 0.99
Validation of family history of cancer in deceased family members. J Natl Cancer Inst (1996) 0.99
Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr (1985) 0.99
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr (1983) 0.98
Linkage of epidermolytic hyperkeratosis to the type II keratin gene cluster on chromosome 12q. Nat Genet (1992) 0.98
Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. Int J Cancer (1997) 0.98
Case-control study of female hormones and eye melanoma. Cancer Res (1989) 0.97
Sjögren-Larsson syndrome is caused by a common mutation in northern European and Swedish patients. J Invest Dermatol (1997) 0.96
Daytime napping: Effects on human direct associative and relational memory. Neurobiol Learn Mem (2010) 0.96
Secondary hyperparathyroidism in patients with ichthyosis is not caused by vitamin D deficiency or ingestion of retinoids. Arch Dermatol (1993) 0.96
The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer (1988) 0.96
The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer (1988) 0.96
Sun exposure and basal cell carcinomas in the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol (1993) 0.96
Validation of a brief screening test for depression in the elderly. Age Ageing (1987) 0.95
Keratin 13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nat Genet (1995) 0.95
The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3. Hum Genet (2000) 0.93
Linkage of autosomal recessive lamellar ichthyosis to chromosome 14q. Am J Hum Genet (1994) 0.93
Familial eosinophilia: clinical and laboratory results on a U.S. kindred. Am J Med Genet (1998) 0.93